Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 39Lymphoid 22Breast 20Gastrointestinal 17Sarcoma 16Genitourinary 16Thoracic 15Head & Neck 14CNS 14Dermatologic 11Gynecologic 7Plasma cell 6Myeloid 5Other solid neoplasm 4Other neoplasm 4Classical hematology 3Endocrine 1

Conditions

Adrenocortical Carcinoma 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Nivolumab 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Gene Expression Profiling × Endocrine × Clear all
NCT01528956 2016-05-18

Studying Genes in Samples From Younger Patients With Adrenocortical Tumor

Children's Oncology Group

Completed
10 enrolled
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡